Published in Oncotarget on January 12, 2016
Inactivation of FGF8 in early mesoderm reveals an essential role in kidney development. Development (2005) 2.82
NKX-3.1 interacts with prostate-derived Ets factor and regulates the activity of the PSA promoter. Cancer Res (2002) 1.25
Gadd45 in stress signaling, cell cycle control, and apoptosis. Adv Exp Med Biol (2013) 1.11
Two novel VHL targets, TGFBI (BIGH3) and its transactivator KLF10, are up-regulated in renal clear cell carcinoma and other tumors. Biochem Biophys Res Commun (2008) 1.10
Spontaneous release of neuropeptide Y tonically inhibits recurrent mossy fiber synaptic transmission in epileptic brain. J Neurosci (2005) 1.08
Differential expression of galectins in normal, benign and malignant prostate epithelial cells: silencing of galectin-3 expression in prostate cancer by its promoter methylation. Biochem Biophys Res Commun (2007) 1.05
Identification of a biphasic role for genistein in the regulation of prostate cancer growth and metastasis. Cancer Res (2009) 1.04
Akt GSK-3 pathway as a target in genistein-induced inhibition of TRAMP prostate cancer progression toward a poorly differentiated phenotype. Carcinogenesis (2007) 1.01
Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells. Cancer Res (2006) 1.01
Neuropeptide Y in the recurrent mossy fiber pathway. Peptides (2007) 0.97
Integrated analysis of ATM mediated gene and protein expression impacting cellular metabolism. J Proteome Res (2011) 0.97
The significance of TNFAIP8 in prostate cancer response to radiation and docetaxel and disease recurrence. Int J Cancer (2013) 0.97
High ratio of synaptic excitation to synaptic inhibition in hilar ectopic granule cells of pilocarpine-treated rats. J Neurophysiol (2010) 0.96
Mahanine restores RASSF1A expression by down-regulating DNMT1 and DNMT3B in prostate cancer cells. Mol Cancer (2013) 0.94
Dietary n-3 polyunsaturated fatty acids fail to reduce prostate tumorigenesis in the PB-ErbB-2 x Pten(+/-) preclinical mouse model. Cell Cycle (2010) 0.91
Fluorescent epigenetic small molecule induces expression of the tumor suppressor ras-association domain family 1A and inhibits human prostate xenograft. J Med Chem (2010) 0.87
Identification of both Myt-1 and Wee-1 as necessary mediators of the p21-independent inactivation of the cdc-2/cyclin B1 complex and growth inhibition of TRAMP cancer cells by genistein. Prostate (2006) 0.87
Genistein induces the metastasis suppressor kangai-1 which mediates its anti-invasive effects in TRAMP cancer cells. Biochem Biophys Res Commun (2007) 0.86
Mahanine reverses an epigenetically silenced tumor suppressor gene RASSF1A in human prostate cancer cells. Biochem Biophys Res Commun (2007) 0.86
Mahanine inhibits growth and induces apoptosis in prostate cancer cells through the deactivation of Akt and activation of caspases. Prostate (2006) 0.85
Inositol hexaphosphate represses telomerase activity and translocates TERT from the nucleus in mouse and human prostate cancer cells via the deactivation of Akt and PKCalpha. Biochem Biophys Res Commun (2006) 0.84
A naturally derived small molecule disrupts ligand-dependent and ligand-independent androgen receptor signaling in human prostate cancer cells. Mol Cancer Ther (2013) 0.83
Physiologically achievable concentrations of genistein enhance telomerase activity in prostate cancer cells via the activation of STAT3. Carcinogenesis (2007) 0.83
Effects of sazetidine-A, a selective α4β2* nicotinic receptor desensitizing agent, on body temperature regulation in mice and rats. Eur J Pharmacol (2012) 0.83
Telomerase reverse transcriptase regulates the expression of a key cell cycle regulator, cyclin D1. Biochem Biophys Res Commun (2006) 0.82
Human fibroblasts for large-scale "omics" investigations of ATM gene function. Adv Exp Med Biol (2011) 0.82
Design, synthesis, and in vitro evaluation of potential West Nile virus protease inhibitors based on the 1-oxo-1,2,3,4-tetrahydroisoquinoline and 1-oxo-1,2-dihydroisoquinoline scaffolds. J Comb Chem (2010) 0.81
FGFR2 intronic SNPs and breast cancer risk: associations with tumor characteristics and interactions with exogenous exposures and other known breast cancer risk factors. Int J Cancer (2010) 0.79
Protein purification-free method of binding affinity determination by microscale thermophoresis. J Vis Exp (2013) 0.79
The cellular functions of RASSF1A and its inactivation in prostate cancer. J Carcinog (2012) 0.79
Inheritance of susceptibility to induction of nephroblastomas in the Noble rat. Differentiation (2009) 0.77
Recursive method for phase retrieval using transport of intensity and its applications. Appl Opt (2016) 0.75
Application of up-sampling and resolution scaling to Fresnel reconstruction of digital holograms. Appl Opt (2015) 0.75
Non-recursive transport of intensity phase retrieval with the transport of phase. Appl Opt (2022) 0.75
Digital tomographic compressive holographic reconstruction of three-dimensional objects in transmissive and reflective geometries. Appl Opt (2013) 0.75
Digital Holography and 3D Imaging: introduction to the joint feature issue in Applied Optics and Journal of the Optical Society of America A. Appl Opt (2022) 0.75
Digital Holography and 3D Imaging: introduction to the joint feature issue in Applied Optics and Journal of the Optical Society of America A. J Opt Soc Am A Opt Image Sci Vis (2022) 0.75
Gaussian-beam-induced photorefractive birefringence and its application to radio-frequency signal excision. Opt Lett (2002) 0.75
Beam shaping by use of hybrid acousto-optics with feedback. Appl Opt (2005) 0.75
Sleep and Breast Cancer in the Western New York Exposures and Breast Cancer (WEB) Study. J Clin Sleep Med (2017) 0.75
Digital Holography and 3D Imaging: introduction to the joint feature issue in Applied Optics and Journal of the Optical Society of America B. Appl Opt (2017) 0.75
Use of structured light in 3D reconstruction of transparent objects. Appl Opt (2022) 0.75